alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2558 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2558

 To extend the temporary suspension of duty on artichokes, prepared or 
    preserved otherwise than by vinegar or acetic acid, not frozen.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

Mrs. Feinstein introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To extend the temporary suspension of duty on artichokes, prepared or 
    preserved otherwise than by vinegar or acetic acid, not frozen.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ARTICHOKES, PREPARED OR PRESERVED OTHERWISE THAN BY VINEGAR 
              OR ACETIC ACID, NOT FROZEN.

    (a) In General.--Heading 9902.03.89 of the Harmonized Tariff 
Schedule of the United States (relating to artichokes, prepared or 
preserved otherwise than by vinegar or acetic acid, not frozen) is 
amended by striking the date in the effective period column and 
inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Fourth Court of Appeals

San Antonio, Texas

JUDGMENT

No. 04-17-00496-CR

Tracy Diane GRIER,

Appellant

v.

The STATE of Texas,

Appellee

From the 198th Judicial District Court, Kerr County, Texas

Trial Court No. B12462

Honorable N. Keith Williams, Judge Presiding

BEFORE CHIEF JUSTICE MARION, JUSTICE ANGELINI, AND JUSTICE RIOS

In accordance with this court’s memorandum opinion of this date, the judgment of the trial 

court is AFFIRMED.

SIGNED June 13, 2018.

_____________________________

Karen Angelini, Justice
CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In  connection  with the Annual Report on Form 10-KSB of  Optionable,  Inc. (the
"Company")  for the  fiscal  year ended  December  31,  2005,  as filed with the
Securities  and  Exchange  Commission  on the date  hereof (the  "Report"),  the
undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350:

     (1) The Report fully  complies  with the  requirements  of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.


Date:  March 15, 2006                                    /s/ Kevin Cassidy
                                                        -----------------
                                                        Kevin Cassidy
                                                        Chief Executive Officer
II 

112TH CONGRESS 

2D SESSION S. 2610 

To extend the temporary suspension of duty on Esfenvalerate technical. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. COONS introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on Esfenvalerate 

technical. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ESFENVALERATE TECHNICAL. 

4 (a) IN GENERAL.—Heading 9902.01.45 of the Har5 monized Tariff Schedule of the United States (relating to 

6 (S)-cyano(3-phenoxyphenyl)methyl (S)-4-chloro-α-(1- 

7 methylethylbenzeneacetate (Esfenvalerate)) is amended by 

8 striking the date in the effective period column and insert9 ing ‘‘12/31/2015’’. 

10 (b) EFFECTIVE DATE.—The amendment made by 

11 subsection (a) applies with respect to goods entered, or 


jbell on DSK7SPTVN1PROD with BILLS
2 

•S 2610 IS

1 withdrawn from warehouse for consumption, on or after 

2 the 15th day after the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

*Time and Date:*

7 p.m.-5 p.m., February 25, 2009 (Closed).

7 p.m.-5 p.m., February 26, 2009 (Closed).

7 p.m.-5 p.m., February 27, 2009 (Closed).

*Place:*                         Courtyard Greenville, 2225 Stantonsburg Road, Greenville, North Carolina 27834, telephone: (252) 329-2900.                    

*Status:*                         The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.                    

*Matters to be Discussed:*                         The meeting will include the review, discussion, and evaluation of applications received in response to “Centers for Agricultural Disease and Injury Research, Education and Prevention, PAR06-057.”                    

*Contact Person for More Information:*                         Stephen Olenchock, PhD, Scientific Review Administrator, 1095 Willowdale Road, Morgantown, West Virginia 26505, telephone: (304) 285-6271.                    

                        The Director, Management Analysis and Services Office, has been delegated the authority to sign                         **Federal Register**                         notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.                    

Dated: January 8, 2009.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

 [FR Doc. E9-873 Filed 1-15-09; 8:45 am]

BILLING CODE 4163-18-P
Exhibit 10.79

 

Change Order Form # 9

 

Change order under Agreement dated:  The Development and Clinical Supplies Agreement dated June 19, 2009, as amended by the Amendment dated as of December 31, 2009, the Second Amendment dated as of September 16, 2010, the Third Amendment dated as of September 29, 2010 and the Fourth Amendment dated March 2, 2011 (the “Agreement”).

 

Between:  Radius Health, Inc and 3M

 

Project Name:  For the development of Radius’s BA-058 compound delivered via 3M’s Microstructured Transdermal Delivery System

 

Change requested by:  3M

 

Name:  Tom Fenn

Company:  3M

Date:  22 July 2011

Description of change:  Change Order to conduct initial manufacturing experiments for new strength, [*]mcg/array.

 

Radius is requesting 3M manufacture a new lower strength [*] mcg/array.  3M has not coated this strength before and proposes the following series of experiments:

 

Exp #1 - First screening of formulations and well depths on ATS in existing wells - total of 6.5 days

Exp #2 - Second screening of formulations and well depths on ATS in existing wells - total of 6.5 days

Exp #3 - Verification of well depth and wt% BA058 - total of 6.25 days

 

Efforts include drafting and approval of protocols, preparation of RTC and arrays, GMP experimentation, HPLC analysis and visual examination of coated arrays.

 

We estimate this work will be conducted over a 4 week period and require approximately 300 hours.

 

Except to the extent expressly amended by this Change Order, the terms and conditions of the Agreement remain in full force and effect.  The term “Agreement”, as used in the Agreement, shall henceforth be deemed to be a reference to the Agreement as amended by this Change Order.

 

Requested task, dates and costs are approved by:

	
Company:   Radius Health, Inc
    	
Company:   3M
    
	
Name:   Nick Harvey
    	
Name:   Mary Mathisen
    
	
Signature:
    	
/s/   Nick Harvey
    	
 
    	
Signature:
    	
/s/   Mary Mathisen
    
	
Position:   CFO
    	
Position:   Commercialization Mgr
    
					


 




* Confidential Treatment Requested by the Registrant.  Redacted Potion Filed Separately with the Commission.

 











 

	
Date   (dd/mm/yy): August 10, 2011
    	
Date   (dd/mm/yy): 12 August 2011
# Official Journal L 367/2021

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 367 |
| | |
| English edition | Legislation | Volume 6415 October 2021 |

ISSN 1977-0677

Official Journal

of the European Union

L 367

English edition

Legislation

Volume 6415 October 2021

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | INTERNATIONAL AGREEMENTS |
| | * | Notice concerning the date of entry into force of the Agreement in the form of an Exchange of Letters between the European Union and the Republic of Cuba pursuant to Article XXVIII of the General Agreement on Tariffs and Trade (GATT) 1994 relating to the modification of concessions on all the tariff-rate quotas included in the EU Schedule CLXXV as a consequence of the United Kingdom's withdrawal from the European Union | 1 |
| | | REGULATIONS |
| | * | Regulation (EU) 2021/1814 of the European Central Bank of 7 October 2021 amending Regulation (EC) No 2157/1999 on the powers of the European Central Bank to impose sanctions (ECB/2021/46) | 2 |
| | | DECISIONS |
| | * | Decision (EU) 2021/1815 of the European Central Bank of 7 October 2021 on the methodology applied for the calculation of sanctions for non-compliance with the requirement to hold minimum reserves and related minimum reserve requirements (ECB/2021/45) | 4 |

Contents

II   Non-legislative acts

page

INTERNATIONAL AGREEMENTS

*

Notice concerning the date of entry into force of the Agreement in the form of an Exchange of Letters between the European Union and the Republic of Cuba pursuant to Article XXVIII of the General Agreement on Tariffs and Trade (GATT) 1994 relating to the modification of concessions on all the tariff-rate quotas included in the EU Schedule CLXXV as a consequence of the United Kingdom's withdrawal from the European Union

1

REGULATIONS

*

Regulation (EU) 2021/1814 of the European Central Bank of 7 October 2021 amending Regulation (EC) No 2157/1999 on the powers of the European Central Bank to impose sanctions (ECB/2021/46)

2

DECISIONS

*

Decision (EU) 2021/1815 of the European Central Bank of 7 October 2021 on the methodology applied for the calculation of sanctions for non-compliance with the requirement to hold minimum reserves and related minimum reserve requirements (ECB/2021/45)

4

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2518 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2518

   To suspend temporarily the duty on aqueous mixtures of polyvinyl 
                   alcohol and polyvinyl pyrrolidone.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

 Ms. Landrieu introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
   To suspend temporarily the duty on aqueous mixtures of polyvinyl 
                   alcohol and polyvinyl pyrrolidone.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. AQUEOUS MIXTURES OF POLYVINYL ALCOHOL AND POLYVINYL 
              PYRROLIDONE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.01.00       Aqueous mixtures    Free         No change        No change        On or before 12/ ''.
                          of polyvinyl                                                       31/2015.......
                          alcohol (CAS No.
                          98002-48-3) and
                          polyvinyl
                          pyrrolidone (CAS
                          No. 9003-39-8)
                          (provided for in
                          subheading
                          3905.99.80)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
Garnard PRATT, Appellant, v. The STATE of Florida, Appellee.

No. 3D18-170

District Court of Appeal of Florida, Third District.

Opinion filed March 14, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2612 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2612

  To extend the temporary suspension of duty on mixtures of methyl 2-
   [[[[[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-
  yl]amino]carbonyl]amino]-sulfonyl]-3-methylbenzoate and application 
                               adjuvants.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Coons introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To extend the temporary suspension of duty on mixtures of methyl 2-
   [[[[[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-
  yl]amino]carbonyl]amino]-sulfonyl]-3-methylbenzoate and application 
                               adjuvants.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MIXTURES OF METHYL 2-[[[[[4-(DIMETHYLAMINO)-6-(2,2,2-
              TRIFLUOROETHOXY)-1,3,5-TRIAZIN-2-
              YL]AMINO]CARBONYL]AMINO]-SULFONYL]-3-METHYLBENZOATE AND 
              APPLICATION ADJUVANTS.

    (a) In General.--Heading 9902.05.01 of the Harmonized Tariff 
Schedule of the United States (relating to mixtures of methyl 2-[[[[[4-
(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-
yl]amino]carbonyl]amino]-sulfonyl]-3-methylbenzoate and application 
adjuvants) is amended by striking the date in the effective period 
column and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2724 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2724

       To suspend temporarily the duty on (RS)-1-(b-allyloxy-2,4-
                      dichlorophenethyl)imidazole.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Casey introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
       To suspend temporarily the duty on (RS)-1-(b-allyloxy-2,4-
                      dichlorophenethyl)imidazole.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. (RS)-1-(B-ALLYLOXY-2,4-DICHLOROPHENETHYL) IMIDAZOLE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      (RS)-1-(b-allyloxy- Free         No change        No change        On or before 12/  ''.
                        2,4-                                                               31/2015.......
                        dichlorophenethyl
                        )imidazole (CAS
                        No. 35554-44-0)
                        (provided for in
                        subheading
                        2933.29.35)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 1195 Introduced in Senate (IS)]

<DOC>

118th CONGRESS
  1st Session
                                S. 1195

 To amend the Internal Revenue Code of 1986 to repeal the excise taxes 
              on taxable chemicals and taxable substances.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 19, 2023

    Mr. Cruz (for himself, Mr. Kennedy, Mr. Lee, and Mr. Barrasso) 
introduced the following bill; which was read twice and referred to the 
                          Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To amend the Internal Revenue Code of 1986 to repeal the excise taxes 
              on taxable chemicals and taxable substances.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Chemical Tax Repeal Act''.

SEC. 2. REPEAL OF EXCISE TAXES ON CERTAIN CHEMICALS AND SUBSTANCES.

    (a) In General.--Chapter 38 of the Internal Revenue Code of 1986 is 
amended by striking subchapters B and C (and by striking the items 
relating to such subchapters in the table of subchapters for such 
chapter).
    (b) Effective Date.--The amendments made by this section shall take 
effect on January 1, 2023.
                                 <all>
```
CERTIFICATIONS

I, Henk Van Alphen, certify that:

1.

I have reviewed this annual report on Form 40-F of Cardero Resource Corp.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;

4.

The issuers other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the issuer and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Evaluated the effectiveness of the issuers disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the issuers internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the issuers internal control over financial reporting; and

5.

The issuers other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuers auditors and the audit committee of the issuers board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuers ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuers internal control over financial reporting.



/s/Henk Van Alphen

Henk Van Alphen
  President and Chief Executive Officer



Date:  April 29, 2005
Jimmy Lee FIELDS, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D17-2262

District Court of Appeal of Florida, Second District.

March 28, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.